Newgenivf Group Ltd current report, Q2 FY2024

NewGenIvf Group Limited — Form 6-K Summary

Business context and reporting period

NewGenIvf Group Limited, a foreign private issuer headquartered in Bangkok, Thailand, filed this Form 6-K for May 2024. The filing reports Nasdaq listing-compliance notices received on May 24, 2024 and disclosed by press release on May 28, 2024.

Key financial and market metrics

  • The Class A ordinary shares failed to meet Nasdaq’s minimum Market Value of Publicly Held Shares requirement of $15 million for 35 consecutive business days.
  • The Class A ordinary shares also failed to meet Nasdaq’s minimum Market Value of Listed Securities requirement of $50 million for 35 consecutive business days.
  • The filing does not provide revenue, profit, cash flow, margins, debt, cash, liquidity, or other operating financial metrics.

Material changes versus the prior comparable period

The filing does not present comparative financial results. The material development is the receipt of two Nasdaq deficiency letters relating to market capitalization and publicly held share value.

Guidance, outlook, risks, contingencies, and unusual items

  • The deficiencies do not immediately affect the Company’s Nasdaq listing.
  • Nasdaq granted an initial 180-calendar-day compliance period ending November 20, 2024 for both requirements.
  • To regain compliance, the Company must maintain at least $15 million in Market Value of Publicly Held Shares and at least $50 million in Market Value of Listed Securities for a minimum of 10 consecutive business days.
  • If compliance is not restored by the deadline, Nasdaq may issue a delisting notification. The Company may alternatively consider applying to transfer its securities to The Nasdaq Capital Market.
  • Management stated that it intends to monitor the relevant market values and may consider available options to regain compliance.

Important facts for investors to verify

  • Whether the Company regained compliance with either Nasdaq requirement before November 20, 2024.
  • Any subsequent Nasdaq delisting notice, extension, appeal, or transfer application.
  • Changes in the Class A share price, public float, and market capitalization affecting the two requirements.
  • The Company’s underlying financial results, liquidity, capital structure, and operating performance, which are not included in this filing.
  • The contents of Exhibit 99.1, the May 28, 2024 press release.